[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abvc Biopharma Inc (ABVC)

Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 28,678
  • Shares Outstanding, K 26,554
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,910 K
  • EBIT $ -6 M
  • EBITDA $ -6 M
  • 60-Month Beta 0.54
  • Price/Sales 35.85
  • Price/Cash Flow N/A
  • Price/Book 2.00

Options Overview Details

View History
  • Implied Volatility 206.23% (-440.42%)
  • Historical Volatility 127.11%
  • IV Percentile 29%
  • IV Rank 16.08%
  • IV High 1,200.96% on 04/01/26
  • IV Low 15.63% on 09/16/25
  • Expected Move (DTE 21) 0.2295 (22.72%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 93
  • Put/Call OI Ratio 0.59
  • Today's Open Interest 618
  • Open Int (30-Day) 547
  • Expected Range 0.7805 to 1.2395

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9600 +5.21%
on 07/27/26
2.1500 -53.02%
on 07/07/26
-0.5700 (-36.08%)
since 06/30/26
3-Month
0.9600 +5.21%
on 07/27/26
2.1500 -53.02%
on 07/07/26
-0.0200 (-1.94%)
since 04/30/26
52-Week
0.8801 +14.76%
on 03/30/26
3.4000 -70.29%
on 10/07/25
-1.8700 (-64.93%)
since 07/30/25

Most Recent Stories

More News
ABVC BioPharma Receives $200,000 Payment from OncoX BioPharma as Part of Strategic Licensing Agreement

ABVC BioPharma received a $200,000 payment from OncoX as part of a $5 million licensing agreement for oncology products.Quiver AI SummaryABVC BioPharma, Inc. has received a $200,000 payment from OncoX...

ABVC : 1.0100 (-6.48%)
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection

/CNW/ -- USA News Group – Hope is rising in the fight against one of the deadliest cancers in the world, as a new study recently claimed that a blood test can...

ONCY : 0.7533 (+0.04%)
ABVC : 1.0100 (-6.48%)
CTMX : 3.10 (-5.49%)
CADL : 10.01 (+1.42%)
ONC.TO : 1.42 (+2.16%)
AMGN : 385.16 (-0.64%)
Biotech Innovations Drive Hope in Global Fight Against Pancreatic Cancer

USA News Group – Hope is rising in the fight against one of the deadliest cancers in the world, as a new study recently claimed that a blood test can accurately detect early-stage pancreatic cancer with...

ONCY : 0.7533 (+0.04%)
ABVC : 1.0100 (-6.48%)
CTMX : 3.10 (-5.49%)
CADL : 10.01 (+1.42%)
ONC.TO : 1.42 (+2.16%)
AMGN : 385.16 (-0.64%)
ABVC Biopharma (NASDAQ: ABVC) Inks Major Licensing Agreement with Xinnovation Therapeutics for ABV-1504 and ABV-1505

Landmark Licensing Deal for ABVC in China's Growing Healthcare Market ABVC Biopharma, Inc. (NASDAQ: ABVC), a pioneer in the development

ABVC : 1.0100 (-6.48%)
ABVC BioPharma Provides Vitargus® Update on Phase II Site Initiation Visit Conducted at Srinagarind Hospital in Thailand

/PRNewswire/ -- ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS,...

ABVC : 1.0100 (-6.48%)
ABVC BioPharma Receives Registration Approval for Maitake Mushroom Dietary Supplement by the Taiwan Ministry of Health and Welfare

/PRNewswire/ -- ABVC Biopharma, Inc. ("ABVC" or the "Company") (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...

ABVC : 1.0100 (-6.48%)
ABVC BioPharma Provides Vitargus® Update

Phase II Vitargus® Clinical Study Protocol Receives Local Ethics Committee Approval FREMONT, CA, Aug. 02, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire...

ABVC : 1.0100 (-6.48%)

Business Summary

ABVC BioPharma Inc. is a clinical-stage biopharmaceutical company developing botanical-based therapies for central nervous system, ophthalmology and oncology/hematology indications. ABVC BioPharma Inc. is based in SILICON VALLEY, CA.

See More

Key Turning Points

3rd Resistance Point 1.1267
2nd Resistance Point 1.1033
1st Resistance Point 1.0567
Last Price 1.0100
1st Support Level 0.9867
2nd Support Level 0.9633
3rd Support Level 0.9167

See More

52-Week High 3.4000
Fibonacci 61.8% 2.4374
Fibonacci 50% 2.1400
Fibonacci 38.2% 1.8427
Last Price 1.0100
52-Week Low 0.8801

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.